Screener
Radient Pharmaceuticals Corporation RPC Q4 2025 Annual earnings
Reported February 12, 2026 · After market close
Revenue$81.0MBeat by $1.6M
EPS$0.26Beat by $0.01
Revenue estimate$79.4M
EPS estimate$0.25
Next report
Aug 5, 2026 (Tomorrow)Revenue estimate$80.8M
EPS estimate$0.23
Versus estimates
Revenue
Q1 2026$75.0MMiss by $2.0M
Q4 2025$81.0MBeat by $1.6M
Diluted EPS
Q1 2026$0.22Beat by $0.01
Q4 2025$0.26Beat by $0.01
FAQ
- When did Radient Pharmaceuticals Corporation report Q4 2025 earnings?
- Radient Pharmaceuticals Corporation (RPC) reported Q4 2025 earnings on February 12, 2026 after market close.
- What were Radient Pharmaceuticals Corporation's Q4 2025 revenue and EPS?
- Radient Pharmaceuticals Corporation reported revenue of $81.0M and eps of $0.26 for Q4 2025.
- Did Radient Pharmaceuticals Corporation beat estimates in Q4 2025?
- Revenue beat the consensus estimate of $79.4M by $1.6M. EPS beat the consensus estimate of $0.25 by $0.01.
- Where can I find Radient Pharmaceuticals Corporation's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-26-047619) and the 10-K periodic report (0001193125-26-081484) directly on SEC EDGAR. The filing index links above go to sec.gov.
